Opinion|Videos|May 29, 2024
Identifying the Most Impactful Disease Areas and Patient Populations for PDTs
Diana Brixner, PhD, highlights the potential for prescription digital therapeutics (PDTs) to have impact in areas such as facilitating behavioral change for mental health conditions and strengthening adherence for complex disease states with intricate drug regimens.
Advertisement
Episodes in this series
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
PBM Reforms Signed Into Law, Reshaping Medicare Part D Drug Pricing Transparency
2
Prior Authorization Ranked Top Barrier to Health Care Access After Cost
3
FDA Flags Administration Concerns for Aquestive's Noninvasive Epinephrine Film
4
Contributor: The Majority (57.5%) of Commercially Insured Patients Had 1 or More Chronic Conditions in 2024
5
